Administration of valienamine-related disaccharide compounds in reducing inflammation in a sensitized mammal arising from exposure to an antigen
US5814616A · kind A · utility
2Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 1996 |
| Grant date | Sep 29, 1998 |
| Priority date | — |
| Expiry date | Nov 5, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07H15/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of reducing the degree of inflammation arising from a secondary immune response in a mammal due to antigen exposure (challenge) by the administration of valienamine-related disaccharide compounds and the pharmaceutical compositions employed in the method.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.